Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Davis

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Bioconjugate Chemistry|May 16, 2002
Development of a nonviral gene delivery vehicle for systemic applicationSuzie Hwang Pun, Mark E Davis
Nature Reviews. Drug Discovery|December 2, 2004
Cyclodextrin-based pharmaceutics: past, present and futureMark E Davis, Marcus E Brewster
Nucleic Acids Research|January 18, 2006
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imagingDerek W Bartlett, Mark E Davis
Nature Reviews. Drug Discovery|November 17, 2015
Clinical experiences with systemically administered siRNA-based therapeutics in cancerJonathan E Zuckerman, Mark E Davis
Biotechnology and Bioengineering|October 12, 2007
Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticlesDerek W Bartlett, Mark E Davis
Bioconjugate Chemistry|January 16, 2003
Structural effects of carbohydrate-containing polycations on gene delivery. 1. Carbohydrate size and its distance from charge centersTheresa M Reineke, Mark E Davis
Bioconjugate Chemistry|January 16, 2003
Structural effects of carbohydrate-containing polycations on gene delivery. 2. Charge center typeTheresa M Reineke, Mark E Davis
Bioconjugate Chemistry|March 1, 2007
Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticlesDerek W Bartlett, Mark E Davis
Advances in Chronic Kidney Disease|November 12, 2013
Targeting therapeutics to the glomerulus with nanoparticlesJonathan E Zuckerman, Mark E Davis
Molecular Pharmaceutics|January 10, 2020
Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain MetastasesEmily A Wyatt, Mark E Davis
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Bioconjugate Chemistry|May 16, 2002
Development of a nonviral gene delivery vehicle for systemic applicationSuzie Hwang Pun, Mark E Davis
Nature Reviews. Drug Discovery|December 2, 2004
Cyclodextrin-based pharmaceutics: past, present and futureMark E Davis, Marcus E Brewster
Nucleic Acids Research|January 18, 2006
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imagingDerek W Bartlett, Mark E Davis
Nature Reviews. Drug Discovery|November 17, 2015
Clinical experiences with systemically administered siRNA-based therapeutics in cancerJonathan E Zuckerman, Mark E Davis
Biotechnology and Bioengineering|October 12, 2007
Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticlesDerek W Bartlett, Mark E Davis
Bioconjugate Chemistry|January 16, 2003
Structural effects of carbohydrate-containing polycations on gene delivery. 1. Carbohydrate size and its distance from charge centersTheresa M Reineke, Mark E Davis
Bioconjugate Chemistry|January 16, 2003
Structural effects of carbohydrate-containing polycations on gene delivery. 2. Charge center typeTheresa M Reineke, Mark E Davis
Bioconjugate Chemistry|March 1, 2007
Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticlesDerek W Bartlett, Mark E Davis
Advances in Chronic Kidney Disease|November 12, 2013
Targeting therapeutics to the glomerulus with nanoparticlesJonathan E Zuckerman, Mark E Davis
Molecular Pharmaceutics|January 10, 2020
Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain MetastasesEmily A Wyatt, Mark E Davis
Pageof 12